COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon

Monitoring acute heart patients at home linked to considerable cost savings

The new report could go on to help guide decisions made by CMS and hospital leadership teams for years to come.

married marriage money fraud scandal

Brazen marital healthcare scheme ends with guilty pleas

A former Alabama doctor and her wife faced a slew of charges related to healthcare billing fraud, misuse of PPE loan funds and illegal distribution of opiates.

CityMD agrees to $12M settlement over alleged COVID claims fraud

The company cooperated with a DoJ investigation into COVID-19 tests being erroneously billed to the federal government.

physician tracking patient data and reporting on outcomes

Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes

Healthcare's ongoing shift toward value-based care is a good thing, Joynt Maddox explained, but its implementation has been far from ideal. She also discussed population health, the pandemic, health disparities and the rising influence of private equity investments.

covid cancer connection

Does Covid-19 raise risk for cancers—including rare ones?

A growing set of anecdotes has some physicians suspecting a link.

FDA panel recommends new COVID-19 booster

Booster uptake rates remain low. To date, only 22.5% of Americans received an annual COVID-19 shot from 2023.

H5N1 bird flu in cows

Worries rise over bird flu in cows

Infectious disease experts are ratcheting up their watchfulness of the H5N1 influenza virus. That’s because the strain of “bird flu” has continued turning up in domestic livestock.

avian flu H5N1 in domestic cattle cows

Bird flu in cows: Interesting anomaly or troubling harbinger of things to come?

The avian influenza virus H5N1 has only turned up in two humans in the U.S., but its recent spread to dairy cattle has some experts on at least slightly elevated alert.

Displaying 1 - 8 of 403

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.